DailyStocks Stock Article Search

https://www.fool.com/retirement/2024/04/14/turning-73-in-2024-its-time-to-get-ready-for-your/?source=iedfolrf0000001 Apr 14, 2024 - It's important to know the rules of RMDs so you can plan accordingly and avoid penalties. 0

https://seekingalpha.com/news/4089446-needham-sees-bsx-cnmd-rmd-beating-street-despite-medtech-slow-down?source=feed_sector_healthcare Apr 14, 2024 - Needham estimates Q1 medtech sales grew less than expected, but that Boston Scientific, CONMED, ResMed and Surmodics should still be able to beat the Street. Read more here. 0

https://www.fool.com/investing/2024/04/17/why-eli-lilly-stock-beat-the-market-today-while-re/?source=iedfolrf0000001 Apr 17, 2024 - The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals. 0

https://seekingalpha.com/article/4664838-resmed-inc-rmd-q2-2024-earnings-call-transcript?source=feed_sector_transcripts Jan 24, 2024 - ResMed Inc. (NYSE:NYSE:RMD) Q2 2024 Earnings Conference Call January 24, 2024 4:30 PM ETCompany ParticipantsAmy Wakeham - Chief Communications and Investor... 0

https://www.zacks.com/stock/news/2196711/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2196711 Dec 12, 2023 - Investors continue to be optimistic about ResMed (RMD) due to the sustained growth in the SaaS business. 0

https://www.zacks.com/stock/news/2211621/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2211621 Jan 17, 2024 - Investors are optimistic about ResMed (RMD) on strong uptake of the myAir app with AirSense11. 0

https://www.zacks.com/stock/news/2213008/stay-ahead-of-the-game-with-resmed-rmd-q2-earnings-wall-street-s-insights-on-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2213008 Jan 19, 2024 - Evaluate the expected performance of ResMed (RMD) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. 0

https://www.zacks.com/stock/news/2215273/resmed-rmd-tops-q2-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2215273 Jan 24, 2024 - ResMed (RMD) delivered earnings and revenue surprises of 3.87% and 0.46%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2216027/resmed-rmd-q2-earnings-beat-estimates-margins-expand?cid=CS-ZC-FT-analyst_blog|earnings_article-2216027 Jan 25, 2024 - ResMed's (RMD) Q2 results reflect cost discipline to support an acceleration in profitability. 0

https://www.zacks.com/stock/news/2228766/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2228766 Feb 20, 2024 - Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices. 0